Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.
Year: 1990
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: E C Kohn, R G Steis, E A Sausville, S R Veach, J L Stocker, R Phelps, S Franco, D L Longo, P A Bunn, D C Ihde
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2178301314
